A detailed history of Hall Laurie J Trustee transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hall Laurie J Trustee holds 610 shares of BMY stock, worth $33,049. This represents 0.01% of its overall portfolio holdings.

Number of Shares
610
Previous 610 -0.0%
Holding current value
$33,049
Previous $33,000 24.24%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $43,182 - $48,960
-900 Reduced 59.6%
610 $33,000
Q4 2023

Jan 11, 2024

SELL
$48.48 - $57.85 $143,016 - $170,657
-2,950 Reduced 66.14%
1,510 $77,000
Q3 2023

Oct 12, 2023

SELL
$57.89 - $64.73 $5,789 - $6,473
-100 Reduced 2.19%
4,460 $259,000
Q2 2023

Jul 14, 2023

SELL
$63.71 - $70.74 $12,742 - $14,147
-200 Reduced 4.2%
4,560 $292,000
Q4 2022

Jan 11, 2023

SELL
$68.48 - $81.09 $6,848 - $8,109
-100 Reduced 2.06%
4,760 $342,000
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $13 - $7,684
-100 Reduced 2.02%
4,860 $345,000
Q2 2022

Jul 06, 2022

SELL
$72.62 - $79.98 $10,893 - $11,997
-150 Reduced 2.94%
4,960 $382,000
Q3 2021

Oct 04, 2021

SELL
$59.17 - $69.31 $5,917 - $6,931
-100 Reduced 1.92%
5,110 $303,000
Q2 2021

Jul 07, 2021

SELL
$61.91 - $67.42 $7,553 - $8,225
-122 Reduced 2.29%
5,210 $348,000
Q1 2021

Apr 15, 2021

SELL
$59.34 - $66.74 $115,119 - $129,475
-1,940 Reduced 26.68%
5,332 $337,000
Q4 2020

Jan 25, 2021

SELL
$57.74 - $65.43 $307,176 - $348,087
-5,320 Reduced 42.25%
7,272 $451,000
Q3 2020

Oct 09, 2020

SELL
$57.43 - $63.64 $8,614 - $9,546
-150 Reduced 1.18%
12,592 $759,000
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $581,662 - $758,725
11,820 Added 1282.0%
12,742 $818,000
Q2 2017

Aug 22, 2017

BUY
N/A
922
922 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hall Laurie J Trustee Portfolio

Follow Hall Laurie J Trustee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

News

Stay updated on Hall Laurie J Trustee with notifications on news.